Introduction {#s1}
============

In the subgranular zone (SGZ) of the adult hippocampal dentate gyrus (DG), one of the two neurogenic niches in the adult mammalian brain, new neurons are continuously generated throughout adulthood ([@bib50]; [@bib61]). Adult hippocampal neurogenesis is a highly dynamic and regulated process that evolves slowly over several weeks ([@bib59]). Adult neural stem/ radial glia-like cells (Type I cells) reside at the interface between the SGZ and the hilus, and give rise to rapidly dividing intermediate progenitors (Type 2 cells). These cells migrate a short distance into the SGZ and progressively (via Type 2a and Type 2b intermediate progenitors) differentiate into neuroblasts (Type 3 cells) ([@bib59]; [@bib16]; [@bib3]). Neuroblasts then exit the cell cycle and become immature granule cell neurons, which in turn migrate into the granule cell layer and incorporate into the pre-existing functional hippocampal circuits ([@bib53]).

In the young adult mouse DG as many as 4000 new cells are born daily, but only a subset (\~30%) survive at 4 weeks post-mitosis to become mature granule cell neurons ([@bib9]; [@bib22]; [@bib23]; [@bib40]). The survival of adult-generated granule cells exhibits two critical periods; an early one during the transition from transient amplifying progenitors to neuroblasts and a later one during the integration of the immature neurons ([@bib9]; [@bib22]; [@bib40]; [@bib27]). The early phase is associated with phagocytosis of apoptotic cells by microglia ([@bib40]). GABA-mediated-depolarization and NMDA-receptor-mediated neuronal activity regulate the later phase of survival, at two and three weeks after mitosis respectively ([@bib21]; [@bib49]). However, less is known about the mechanisms responsible for the early death of newborn granule cells which occurs during the first days post mitosis, as cells exit the specialized microenvironment (NSC niche) of the adult SGZ.

There is increasing evidence that differential oxygen tensions may be an important component of the NSC niche and that oxygen sensing can regulate the proliferation, survival and differentiation of neural stem cells and progenitors ([@bib32]; [@bib60]; [@bib28]). Thus, we investigated hypoxia within the SGZ, and whether stabilizing Hypoxia Inducible Factor-1 α (HIF-1α), the master regulator of oxygen homeostasis, influences the early survival of the adult hippocampal newborn cells.

Results {#s2}
=======

Detection of hypoxic niches and oxidative damage in the adult SGZ {#s2-1}
-----------------------------------------------------------------

We assessed for hypoxia within the SGZ of the adult DG following intraperitoneal injection of the hypoxia marker pimonidazole hydrochloride (Hypoxyprobe, [Figure 1B](#fig1){ref-type="fig"}) ([@bib55]). Pimonidazole (PH) is reductively activated and binds only to cells that have oxygen concentrations less than 14 μM, equivalent to a pO~2~ of 10 mm Hg (1.3% O~2~) ([@bib34]). Pimonidazole labeled hypoxic cells or groups of cells along the inner border of the SGZ ([Figure 1B](#fig1){ref-type="fig"}). Double labeling with selective markers revealed that the majority (71.7 ± 10.4%) of the hypoxic cells were radial glia (GFAP+) and a smaller percentage (28.3 ± 9.5%) were early intermediate progenitor cells (Tbr2+/Dcx-) ([Figure 1C,D](#fig1){ref-type="fig"}) in close proximity to the SGZ. In contrast, none of the hypoxic cells (0%) expressed the neuroblast marker doublecortin (DCX, [Figure 1C,D](#fig1){ref-type="fig"}).10.7554/eLife.08722.003Figure 1.Detection of hypoxia and oxidative stress in SGZ niches of the adult DG.(**A**) Schematic diagram of experimental design. (**B**) Immunostaining with pimonidazole hydrochloride marks hypoxic areas (white arrows) within the adult SGZ (scale bar: 20 μm). (**C**) Pimonidazole-positive cells colocalized with stem cell marker GFAP (red, top row), intermediate progenitor marker Tbr2 (blue, middle row) but not with neuroblast marker DCX (blue, bottom row). The enlargement in the rightmost panel in the top row indicates a hypoxic neural stem cell (green) that colocalizes with a GFAP+ radial glial cell (yellow). A smaller fraction of early progenitors (Tbr2+) also were pimonidazole-positive (middle row, rightmost panel). Scale bar: 15μm left panel, 5 μm right panel. (**D**) Quantification of SGZ cells types expressing pimonidazole. (**E**) Oxidized 8-deoxyguanosine (8OHdG), a marker of oxidized nucleic acids, was not detected in GFAP positive neural stem cells, but in Tbr2- and DCX-expressing intermediate progenitors and neuroblasts (scale bar: 25 μm). (**F**) Quantification of SGZ cell types expressing oxidized 8-deoxyguanosine. For all quantifications data are plotted as mean ± SD.**DOI:** [http://dx.doi.org/10.7554/eLife.08722.003](10.7554/eLife.08722.003)

Shortly after their generation, proliferating intermediate precursors translocate away from the proximal domain and into the intermediate domain ([@bib16]). Thus, we hypothesized that migration away from hypoxic zones might result in oxidative damage as diagrammed in [Figure 1A](#fig1){ref-type="fig"}. Oxidative byproducts were highly localized in cells within the SGZ as assayed by 8-oxo-7,8-dihydro-2\'-deoxyguanosine (8-OHdG) labeling, an established biomarker of nucleic acid oxidative damage ([Figure 1E](#fig1){ref-type="fig"}). Interestingly, phenotypic analysis revealed that 74.6 ± 5.8% of the 8-OHdG positive cells were late intermediate progenitors (Tbr2+/DCX+) and 29.2 ± 12.2% were neuroblasts (DCX+ only) ([Figure 1E,F](#fig1){ref-type="fig"}). Thus, a subset of newborn cells in the SGZ undergoes oxidative damage during their early migration and differentiation.

Stabilizing hypoxia inducible factor-1α {#s2-2}
---------------------------------------

The most critical survival period for adult-generated dentate granule cells occurs during the first few days post mitosis, as they differentiate from late intermediate progenitors to neuroblasts ([@bib9]; [@bib22]; [@bib40]; [@bib27]). In order to test the role of oxidative damage in this early phase of apoptosis, we used the hypoxia mimetic agent, Dimethyloxallyl glycine (DMOG) ([@bib19]). Hypoxia Inducible Factor-1 α (HIF-1α), the master regulator of oxygen homeostasis, is enzymatically degraded under normoxia by propyl hydroxylases ([@bib38]). DMOG suppresses propyl hydroxylase, thus stabilizing/enhancing HIF-1α activity under normoxic conditions ([@bib19]).

We treated adult mice with DMOG (50 mg/kg once daily) or vehicle for 3 days. Consistent with stabilization of HIF-1α by DMOG, mRNA levels of HIF-1α as well as its downstream targets VEGF, EPO and LEF-1, were significantly higher after 3 days of DMOG treatment ([Figure 2A](#fig2){ref-type="fig"}). As expected given the effect on downstream targets, DMOG treatment also increased HIF-1α protein levels ([Figure 2B](#fig2){ref-type="fig"}, p = 0.03). The increase in *HIF1α* mRNA levels occurs because of autoregulation of transcription by hypoxia response elements in the *HIF1α* promoter ([@bib20]). Hypoxia also increases phosphorylation of Akt (Ser^473^), a serine/threonine kinase that promotes cell survival and reduces apoptosis ([@bib2]). Double immunohistochemistry with an antibody that specifically recognizes phosphorylated Akt together with an antibody against the neuroblast/immature neuron marker doublecortin (DCX) ([Figure 2C](#fig2){ref-type="fig"} left panels), revealed that DMOG treatment induced a two-fold increase in the number of phospho-AKT+/DCX+ cells relative to vehicle treated animals (p = 0.01, n = 3 animals, [Figure 2C](#fig2){ref-type="fig"} right panel), also consistent with the hypoxia mimetic action of DMOG.10.7554/eLife.08722.004Figure 2.DMOG stabilized and activated Hif-1α signaling in vivo.(**A**) DMOG treatment elevated mRNA levels of HIF1-α and its downstream targets. HIF1-α, VEGF, EPO and Lef1 in the microdissected DG of animals treated with DMOG for 3 days. (HIF1-α, p = 0.04, n = 3; VEGF, p = 0.03, n = 3, EPO = 0.02, n = 3, Lef1, p = 0.002, n = 3). Data are mean ± SD. (**B**) Representative western blots of DG protein extracts probed with antibody against HIF1-α, from animals treated for 3 days with vehicle or DMOG (n = 3 each group, left panel). Semiquantitative densitometry for HIF1-α protein normalized to β-tubulin levels (right panel). HIF1-α DG protein levels were significantly elevated in DMOG treated animals. Data are mean ± SD, p = 0.03. (**C**) DMOG increases phosphorylation of Akt (Ser^473^) in DG newborn cells. Representative images of adult DG sections stained with anti-phospho-Akt (green) and anti-DCX (blue) after 3 days treatment with vehicle or DMOG. Note the higher density of phospho-Akt positive cells in the SGZ of DMOG treated animals (below) compared to vehicle treated controls (above) (scale bar: 8 μm). Data are mean ± SD, p = 0.01.**DOI:** [http://dx.doi.org/10.7554/eLife.08722.004](10.7554/eLife.08722.004)

DMOG increases survival, but not proliferation or differentiation {#s2-3}
-----------------------------------------------------------------

Hypoxia in vitro influences neural precursors' proliferation, differentiation and survival ([@bib32]; [@bib60]). There was no significant effect of DMOG on the net proliferation of newborn cells at 3 dpi. (control group, 12901 ± 1870 Ki67+ cells/mm^3^, n = 5 animals, DMOG group 11859 ± 2953 Ki67+ cells/mm^3^, n = 5 animals, p = 0.5, [Figure 3A,B,E](#fig3){ref-type="fig"}). Similarly, there was not a detectable effect on the total density of Tbr2+ cells (control group: 5776 ± 681 cells/mm^3^, DMOG: 7331 ± 1381 cells/mm^3^, p = 0.07, n = 5 animals). At 3 dpi. 43.9 ± 5.8% of the proliferating cells were neural stem cells, nestin-only expressing cells, and 55.3 ± 7.1% were intermediate progenitors expressing both nestin and DCX (n = 4 animals). DMOG did not cause a shift in the proliferative populations of SGZ progenitor at 3 dpi. (41.9 ± 9.53% Ki67+/Nestin+, 58.1 ± 8.33 Ki67+/Nestin+/DCX+, 2-way ANOVA, n = 4 animals, p = 0.56, [Figure 3C,D,F](#fig3){ref-type="fig"}). The composition of the progenitor subtypes, measured as a percentage of BrdU+ cells was unaffected by DMOG treatment at 3, 7, 14, 21 and 28 days post-injection (2-way ANOVA, no interaction between vehicle and DMOG groups, p \>0.99). This data is summarized in [Figure 3G](#fig3){ref-type="fig"}. Specifically, at 3 dpi. BrdU+ cells consisted mainly of late intermediate progenitors (Tbr2+/DCX+) and neuroblasts (Tbr2-/DCX+), and a small number of early intermediate progenitors (Tbr2+/DCX-). At 7 dpi., the proportion of BrdU+ cells colabeled with Tbr2+/DCX+ decreased, whereas the proportion expressing only DCX+ increased, reflecting a shift towards immature neurons. By 14 dpi. Tbr2+ cells were not detected in either group with the majority of the BrdU+ cells expressing DCX. In the subsequent two weeks there was a significant decrease in the number of BrdU+/DCX+ cells consistent with lineage progression to mature neurons. DMOG had no effect on the total volume of the dentate gyrus (Control: 0.61 mm^3^ ± 0.02, n = 3 animals, DMOG: 0.59 ± 0.04, n = animals, p = 0.89), indicating that there were no macroscopic changes in the tissue.10.7554/eLife.08722.005Figure 3.DMOG does not affect the proliferation and differentiation of 3 day old cells in the adult DG.(**A,B**) Representative images of proliferating cells Ki67+ cells in the SGZ (A, B, scale bar: 100 μm). (**C,D**) Triple labeling with Ki67/ Nestin/DCX (C, D, scale bar: 10 μm). (**E**) The density of proliferating cells (Ki67+) was comparable between vehicle controls and DMOG treated animals. (**F**) The proportion of the DG proliferative progenitors remained unaltered following DMOG administration. (**G**) To analyze the phenotype of Brdu+ cells, brains were collected 3, 7, 14, 21 and 28 days after two pulses of BrdU (300 mg/kg with a 4 hr interval between doses) and triple labeled with BrdU/Tbr2/DCX. DMOG treatment did not affect the composition of the SGZ progenitor subtypes at any of the examined time-points. For all quantifications data are plotted as mean ± SD. The percentages at each time point are as follows: 3 dpi.: Control: 8.8 ± 3.2% Tbr2+/DCX-, 16.78 ± 3.6% Tbr2+/DCX+, 68.4 ± 2.7 Tbr2-/DCX+; DMOG: 7.8 ± 1.1% Tbr2+/DCX-, 18.8 ± 1.9% Tbr2+/DCX+, 70.7 ± 2.9% Tbr2-/DCX+. 7 dpi.: Control: 8.4 ± 3.2% Tbr2+/DCX+, 91 ± 3.1% Tbr2-/DCX+; DMOG: 6.8 ± 1.8% Tbr2+/DCX+, 93.2 ± 1.7%. 14 dpi.: Control, 94 ± 5.6% Tbr2-/DCX+; DMOG: 95 ± 2.5% Tbr2-/DCX+. 21 and 28 dpi.: Control: 21 dpi. 33 ± 3.2% Tbr2-/DCX+, 28 dpi. 7.6 ± 2% Tbr2-/DCX+; DMOG: 21 dpi 37.2 ± 6.2% Tbr2-/DCX+, 28 dpi. 7.9 ± 8.4% Tbr2-/DCX+.**DOI:** [http://dx.doi.org/10.7554/eLife.08722.005](10.7554/eLife.08722.005)

To assay the effect of DMOG on early cell survival, dividing cells were pulse-labeled with BrdU in adult mice just prior to DMOG administration, and the number of BrdU-labeled cells in the dentate gyrus was counted at several timepoints post-BrdU injection (dpi) ([Figure 4A](#fig4){ref-type="fig"}). DMOG resulted in an increase of BrdU labeled nuclei in the SGZ ([Figure 4B](#fig4){ref-type="fig"}). Quantitative analysis of the BrdU+ cells showed a significant effect of DMOG on survival of newborn cells in the SGZ (2-way ANOVA, p = 0.0002, [Figure 4C](#fig4){ref-type="fig"}). One day of DMOG treatment did not alter the number of BrdU+ cells, consistent with no effect on proliferation (p = 0.49, n = 6 animals, [Figure 4C](#fig4){ref-type="fig"}). However, DMOG significantly increased the survival of BrdU+ cells by 3 days post-mitosis (p \<0.0001, n = 12 animals). Interestingly, the relative increase in BrdU-labelled cells in DMOG persisted at later time points (7 dpi., p = 0.0017, n = 8 animals; 14 dpi., p = 0.003, n = 6; 21 dpi., p = 0.007, n = 6; 28 dpi., p = 0.01, n = 6), as assessed by the rate of BrdU+ cell loss between 3 and 28 dpi. (Comparison of fits, p = 0.5, F = 0.7). To delineate the effective time window for the action on adult newborn granule cell survival by 28 dpi., dividing cells were labeled with BrdU at day zero, then exposed to DMOG from 0--3, 0--7 or 7--14 days ([Figure 4D](#fig4){ref-type="fig"}). Exposure to DMOG for the first three day post-mitosis resulted in a 33% increase in survival (p = 0.023, n = 3), whereas exposure for 7 days did not yield a significant further increase (p = 0.23, n = 3). However, DMOG administration from day 7--14, a critical period during which the newborn cells begin to integrate into the hippocampal network, had no effect on their survival (p = 0.76, n = 3). The differentiation of BrdU+ cells into mature neurons (NeuN+) by 28 dpi. was not affected by exposure to DMOG for either the first 3 or 7 days post mitosis (BrdU+NeuN+/BrdU+: 0--3 days, Vehicle: 96 ± 4%, DMOG: 95 ± 2%, n = 3; 0--7 days, Vehicle: 98 ± 3%, DMOG: 96 ± 2%, n = 3, 2-way ANOVA p = 0.8). The above results indicate that the hypoxia mimetic agent DMOG does not alter the proliferation or differentiation of newborn cells in the adult DG, but rather specifically promotes their survival during the first few days post-mitosis, during their transition from intermediate progenitors to neuroblasts.10.7554/eLife.08722.006Figure 4.Hypoxia mimetic agent DMOG increases early survival of newborn cells in the adult SGZ.(**A**) The schema shows the experimental design for BrdU pulse labeling of newborn cells at day 0 followed by 3 days treatment with DMOG or vehicle and the different timepoints studied thereafter. (**B**) Representative immunofluorescence in sections of adult DG treated either with vehicle or with DMOG for 3 days double labeled with anti-BrdU and anti-Tbr2, which increased BrdU+ cells following DMOG treatment (scale bar: 100 μm). (**C**) Quantification of the BrdU positive cells along the time course of 28 days post injection (dpi) following 3-day treatment with vehicle or DMOG. (**D**) Quantification of the survival of BrdU positive cells at 28 dpi. following different DMOG treatment periods. For all quantifications data are plotted as mean ± SD (\*p \<0.05;\*\*p \<0.01;\*\*\*p \<0.001).**DOI:** [http://dx.doi.org/10.7554/eLife.08722.006](10.7554/eLife.08722.006)

Apoptotic newborn cells in the DG are rapidly phagocytosed and cleared by unchallenged microglia ([@bib40]); rendering apoptosis hard to detect and evaluate with apoptotic markers such as TUNEL and activated-Caspase-3. Because the pro-apoptotic gene *Bax* mediates programmed cell death of adult-generated hippocampal cells ([@bib45]; [@bib35]), we hypothesized that DMOG treatment should not affect the survival of cells lacking *Bax*. To test this idea, the dentate gyrus of wildtype and *Bax^fl/fl^* mice was co-injected with a nuclear-Cre-GFP encoding retrovirus together with a control retrovirus encoding mCherry ([Figure 5A](#fig5){ref-type="fig"}). These MMLV-based retroviral constructs selectively target the same population of adult-born granule cells ([@bib61]), and could be used to count the numbers of labeled adult-born cells and selectively inhibit Bax expression from Cre-retrovirus infected cells. The ratio of nuclear-Cre-GFP expressing cells to the mCherry-expressing cells in *Bax^fl/fl^* animals as early as 7 dpi., provides a measure of survival of newborn cells, independent of possible variation in injection sites and viral titers. The ratio of Cre-GFP/ mCherry cells was increased in vehicle treated *Bax^fl/fl^* compared to WT animals at 7 dpi. ([Figure 5B,C](#fig5){ref-type="fig"}, 31.7 ± 10.3%, p = 0.002), indicating that loss of Bax augments the survival of adult-born cells at one week post-mitosis. Treatment with DMOG for 7 days post injection decreased the Cre-GFP/ mCherry ratio compared to *Bax^fl/fl^* vehicle treated animals ([Figure 5B,C](#fig5){ref-type="fig"}, 30 ± 9.4%, p = 0.03), consistent with a DMOG-mediated increase in survival in mCherry+ cells. Together our results strongly suggest activation of HIF-1α signaling enhances the early phase of survival of the newborn cells in the adult DG.10.7554/eLife.08722.007Figure 5.DMOG mimics the ablation of pro-apoptotic gene Bax in promoting survival of SGZ newborn cells.(**A**) A fixed ratio mixture of two retoviruses (encoding nuclear Cre-GFP and mCherry) was injected into the adult DG of WT and *Bax^fl/fl^* mice. Survival of the newborn cells was analyzed at 7 days post injection following treatment with either vehicle or DMOG. (**B**) Representative images of virus-labeled cells from co-injection experiments in WT mice treated with vehicle, *Bax^fl/fl^* mice treated with vehicle and *Bax^fl/fl^* mice treated with DMOG (scale bar: left 100 μm, right 20 μm). (**C**) The ratio of Cre-positive to mCherry-positive cells at 7 dpi was used as a measure cell survival (see text). Data are plotted as mean ± SD. \*: WT+ Vehicle vs *Bax^fl/fl^* + Vehicle, p = 0.002; \#: *Bax^fl/fl^* + Vehicle vs *Bax^fl/fl^* + DMOG, p = 0.03; WT+ Vehicle vs *Bax^fl/fl^* vs DMOG: not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.08722.007](10.7554/eLife.08722.007)

Role of neuronal activity {#s2-4}
-------------------------

Neuronal survival can be activity-dependent ([@bib21]; [@bib49]), thus we investigated whether newborn granule cells have received synaptic innervation by three days post-mitosis, the time point at which DMOG maximally increased survival. Acute slices from wildtype animals were prepared 3 days after retroviral infection and GFP-expressing 3 day old cells were identified using fluorescence microscopy and recorded using whole-cell voltage clamp techniques. Labeled cells were predominantly located in the subgranular zone as expected, with passive membrane properties consistent with immature neuronal precursors (R~input~ = 13.2 ± 1.9 GΩ, C~m~ = 4.8 ± 0.5 pF, n = 11 cells), including a fast inward current in response to a depolarizing voltage step consistent with a Na^+^ spike in 9 of 11 cells ([Figure 6A](#fig6){ref-type="fig"}). Strikingly, none of these cells in wildtype animals had any spontaneous post-synaptic currents (PSCs) in \>5 min of continuous recording per cell (n = 11), compared to an sPSC frequency of 0.55 ± 0.15 Hz in adjacent mature cells (n = 4). Furthermore, none of the 3 day-old cells had any evoked synaptic responses in the middle molecular layer ( \>ten 10-second 8 Hz trains per cell, n = 11; [Figure 6A](#fig6){ref-type="fig"}), despite robust extracellular field potentials in these same slices at the same stimulation intensity (n = 7, data not shown) or large PSCs in neighboring mature cells (n = 4; [Figure 6B](#fig6){ref-type="fig"}). As expected for this feedforward circuit, the same middle molecular layer stimuli also produced repetitive spiking in hilar neurons (data now shown), indicating that hilar mossy cells or GABAergic interneurons were activated by our stimulation but were not functionally connected to 3 day-old cells. Together, these results indicate that there is minimal, if any, synaptic innervation at this maturational stage.10.7554/eLife.08722.008Figure 6.Adult-born granule cells lack synaptic responses 3 days post-mitosis.(**A**) At 3-days post-mitosis, granule cell lack responses to afferent stimulation. Five consecutive sweeps from a retrovirus-labeled 3-day-old cell, recorded in whole-cell voltage clamp mode while stimulating afferent inputs in the middle molecular layer. A -10 mV voltage step at the beginning of each sweep demonstrated the high input resistance of these cells, which lacked any postsynaptic responses to stimulation (dots). (**B**) A mature granule cell immediately adjacent to the cell in A had robust post-synaptic currents to the same stimulation. Right panels: Voltage-dependent sodium current evoked in a 3-day-old granule cell during a step from -70 to -10 mV, demonstrating the neuronal identity of the cell (right upper panel). The voltage-dependent sodium current recorded from a mature granule cell was much larger (right lower panel). (**C**) Representative confocal images of p-CREB+ and c-Fos+ cells in the DG of animals treated with vehicle or DMOG for 3 days (scale bar: 10 μm). (**D**) Quantification of the normalized number of p-CREB+ and c-Fos+ cells in the DG of DMOG treated animals relative to vehicle treated ones. DMOG treatment did not alter the number of p-CREB+ or c-Fos+ cells. Bar charts are mean ± SD.**DOI:** [http://dx.doi.org/10.7554/eLife.08722.008](10.7554/eLife.08722.008)

Likewise DMOG did not affect neuronal activity in immature or mature DG granule cells as measured by immunohistochemistry for the immediate early genes pCREB or c-Fos ([Figure 6C,D](#fig6){ref-type="fig"}), which are widely used as surrogate markers for neural activity ([@bib21]; [@bib24]). Thus the action of DMOG in our experiments cannot be attributed to a non-cell autonomous effect on neuronal activity of granule cells. Labeled cells were quantified as follows: pCREB - (control group, 122535 ± 19273 p-CREB+ cells/mm^3^, n = 4 animals, DMOG group 134051 ± 9733 p-CREB+ cells/mm^3^, n = 4 animals, p = 0.35); c-Fos - (control group, 20175 ± 1025 c-Fos+ cells/mm^3^, n = 4 animals; DMOG group 20646 ± 2766 c-fos+ cells/mm^3^, n = 4 animals; p = 0.9). DMOG treatment also did not affect neuronal activity in the hilus as assayed by double immunohistochemistry with c-Fos and the GABAergic neuronal marker glutamic acid decarboxylase-64 (Gad-67). We detected only sparse activation of hilar mossy cells (Fos+ only) or hilar interneurons (Fos+/GAD67+) under basal conditions, which was unaffected by DMOG (Vehicle, Fos+: 144 ± 55 cells/mm^3^, Fos+/GAD67+: 14 ± 16 cells/mm^3^, n = 4; DMOG, Fos only+: 116 ± 14 cells/mm^3^, n = 4, Fos+/GAD67+: 13 ± 14 cells/mm^3^, n = 4, p = 0.4) These results indicate that stabilization and activation of HIF-1a signaling by DMOG rescues early survival of newborn cells in an activity-independent manner.

Effect of hypoxia on adult DG-derived neurospheres {#s2-5}
--------------------------------------------------

To further test the role of hypoxia, we used the neurosphere assay to examine survival and proliferation of adult DG progenitors ([@bib1]; [@bib10]; [@bib25]). Adult DG neurospheres were generated and cultured for 7 days at ambient oxygen tension (21% O~2~), in the presence of DMOG (100 μM) or in hypoxic conditions (2.5% O~2~). Neurospheres under all three conditions exhibited normal morphology, each containing committed progenitors that co-expressed nestin and doublecortin ([Figure 7A](#fig7){ref-type="fig"}). Treatment with DMOG or reducing O~2~ levels to 2.5% increased the number of neurospheres, a measure of cell survival (p = 0.01 and p = 0.002 respectively), but had no effect on the size of the neurospheres, a measure of cells' proliferation (p = 0.98, [Figure 7B,C](#fig7){ref-type="fig"}). Consistent with enhanced survival DMOG or hypoxia reduced the percentage of apoptotic cells in neurospheres as measured by caspase-3 immunoreactivity (normoxia: 28.1 ± 1.7%; DMOG: 17.7 ± 2.6%, p = 0.01; hypoxia: 11.4 ± 2.3%, p \<0.0001, [Figure 7D--G](#fig7){ref-type="fig"}). The neurosphere assay also enabled us to test the sensitivity of the hypoxic marker pimonidazole hydrochloride (PH), which labeled groups of cells in the SGZ ([Figure 1B](#fig1){ref-type="fig"}). No pimonidazole binding was detected in neurospheres cultured in standard atmospheric culture conditions or in the presence of DMOG, whereas only a small percentage of PH+ cells (10.8 ± 4.4%), were detected in neurospheres cultured in 2.5% O~2~ ([Figure 7H--K](#fig7){ref-type="fig"}), indicating that PH labeling occurs at O~2 ~≤2.5%. Consistent with our in vivo experiments, our neurosphere data results strongly suggest that hypoxia is an essential factor for the survival of DG-derived intermediate progenitors in vitro.10.7554/eLife.08722.009Figure 7.DMOG and Hypoxia increase survival of adult DG- derived neurospheres.(**A**) Representative immunofluorescence image of an adult DG-derived neurosphere, composed of nestin+ and DCX+ progenitors. Quantification of neurosphere diameter (**B**) and number (**C**) in cultures grown at normoxia, in the presence of DMOG or under hypoxia (2.5% O~2~) for 7 days. (**D--F**) Representative immunocytochemistry for activated caspase-3 in neurospheres cultured under the 3 different experimental conditions. (**G**) Quantification of apoptotic (activated Caspase-3+) cells among the total number of cells in neurospheres exposed to normoxia, DMOG or hypoxia for 7 days. (**H--J**). Immunostaining with pimonidazole hydrochloride detected some hypoxic cells only in neurospheres cultured in 2.5% O~2~ for 7 days. (Scale bar: 25 μm). (**K**) Quantification of pimonidazole hydrochloride-positive cells among the total cell number in neurospheres exposed to normoxia, DMOG or hypoxia. Bar charts are mean ± SD (\*p \<0.05; \*\*p \<0.01; \*\*\*p \<0.001).**DOI:** [http://dx.doi.org/10.7554/eLife.08722.009](10.7554/eLife.08722.009)

Discussion {#s3}
==========

A hypoxic niche in the SGZ {#s3-1}
--------------------------

The partial oxygen pressure (pO~2~) and concentration in brain tissue is well below the 40 mm Hg in venous blood exiting the brain and is also heterogeneous ([@bib11]). In rat hippocampus the pO~2~ has been estimated to be 20.3 mmHg ([@bib11]), whereas even more hypoxic regions have been detected in the SGZ of the adult mouse DG ([@bib28]). Using the hypoxia marker, pimonidazole hydrochloride, which labels cells with oxygen levels \<10 mm Hg (1.3%), we found that SGZ stem-cell like-radial glia and early intermediate progenitors lie within hypoxic zones. Interestingly, not all cells in the SGZ were labeled, but were localized to narrow zones of a few cell diameters wide along the hilar border of the SGZ. Only a fraction of GFAP+ or Tbr2+ cells were pimonidazole-positive whereas the hypoxic cell did not label with the proliferating marker Ki67 (data not shown). Thus heterogeneous zones of tissue pO~2~ may reflect some degree of cell-state specificity as well as local metabolic demand that changes constantly even within a small specific area/volume of the brain.

The two major determinants for tissue oxygen concentration are blood flow (oxygen supply) and oxygen consumption rate (cellularity). The latter may predominate in the SGZ with its high ratio of nuclei to blood vessels compared to other brain regions ([@bib28]). Although some neural stem cells are perivascular ([@bib30]; [@bib51]; [@bib31]), it remains to be determined whether these vessels carry highly oxygenated blood or how easily oxygen is distributed to the cell. Interestingly, a recent paper ([@bib46]) revealed that within the SGZ zone only late amplifying progenitors (Tbr2+/DCX+) and horizontal early neuroblasts (Tbr2-/DCX+), among the entire population of SGZ progenitors are in direct contact with blood vessels.

Numerous adult stem cells reside in hypoxic niches, where they maintain a quiescent state depending predominantly on anaerobic glycolysis ([@bib60]; [@bib29]; [@bib33]). Stem cells exhibit different metabolic properties than their differentiated progeny that may promote 'stemness'. However, whether anaerobic metabolism is an adaptation to low oxygen levels in the specific niches in vivo or is an intrinsic stem cell property is still unclear. In either case, our results are consistent with two-photon phosphorescence direct in vivo measurements of local oxygen tension in the bone marrow, which revealed a hypoxic adult stem cell niche with high heterogeneity in local pO~2~ ([@bib42]). Thus our data supports the existence of steep pO~2~ gradients between the neurogenic niche and the granule cell layer.

Tissue oxygen and apoptosis {#s3-2}
---------------------------

Although a microenvironment with low oxygen concentration confers resistance to reactive oxygen species and cytotoxic stressors, stem cells and their progeny are susceptible to changes in redox status upon migration away from hypoxic zones ([@bib29]; [@bib33]; [@bib44]). Interestingly, we detected oxidative byproducts in intermediate progenitors and neuroblasts located adjacent to the hypoxic niches. This correlation suggests that migration of intermediate progenitors away from hypoxic zones leads to oxidative damage, and thus triggers an early phase of apoptosis. In vitro, hypoxic conditions (defined as \<5% O~2~) reduces apoptosis, promotes proliferation, and increases cultured embryonic, adult neural stem cells and neuronal progenitors ([@bib40]; [@bib39]; [@bib43]; [@bib15]; [@bib18]; [@bib8]; [@bib7]; [@bib4]). Deletion of hypoxia-inducible factor-1 alpha subunit (HIF-1α) in vivo, a transcriptional activator mediating adaptive cellular responses to hypoxia, dramatically decreased adult hippocampal neurogenesis ([@bib28]). Additionally, conditional ablation of HIF1-α in adult mouse brain resulted in hydrocephalus, decreased neurogenesis (partly due to an increase in apoptosis) and deficits in spatial memory ([@bib52]). In our experiments, DMOG, an agent that stabilizes HIF1-α under normoxic conditions, reversed the early phase of cell death of newborn cells in the adult dentate gyrus. These results strongly support the idea that transition of progenitors from a hypoxic niche to normal tissue oxygen contributes to cell death.

The time course of survival in the SGZ {#s3-3}
--------------------------------------

Prior studies using mitotic markers such as BrdU found that only 30--50% of adult-born newborn neurons survive by 30 days post-mitosis ([@bib9]; [@bib22]; [@bib27]; [@bib21]; [@bib49]), but these studies often did not investigate survival during the first few days post-mitosis. Thus the prevailing idea, until recently, had been that adult-generated hippocampal granule cell survival is regulated mostly at the immature neuron stage (2--4 weeks post-mitosis), when is affected by neuronal activity and behavior ([@bib21]; [@bib49]; [@bib17]). Our results support two critical periods for survival of newborn cells in the adult SGZ, early (1--4 days post-mitosis) and late (1--3 weeks post-mitosis) with most (2/3rds) of cell death occurring in the first week ([@bib9]; [@bib22]; [@bib40]; [@bib27]; [@bib21]; [@bib49]; [@bib28]). The early apoptosis is likely executed by members of the p53 and Bcl-2 protein families that are key players regulating the apoptotic machinery of adult DG neural precursors and newborn neurons ([@bib45]; [@bib35]; [@bib6]; [@bib14]). Although programmed neuronal death is often activity-regulated, whether there is synaptic innervation during the first few days post-mitosis has been unclear ([@bib41]; [@bib12]). Our results show that at 3 days post-mitosis, adult-born cells demonstrate no detectable neural activity. Rather, we propose that the metabolic milieu of the adult SGZ, a previously underexplored variable of this highly specialized neurogenic niche, plays a critical role in the early survival of adult generated hippocampal granule cells.

Materials and methods {#s4}
=====================

Animals {#s4-1}
-------

All procedures were performed according to the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and were in compliance with approved IACUC protocols at Oregon Health & Science University. Subjects were young adult (six weeks old) C57BL/6J (wildtype) and B6;129-Bax^tm2Sjk^ Bak1^tm1Thsn/J^ (*Bax^fl/fl^*) transgenic mice ([@bib48]). Homozygotic *Bax^fl/fl^* mutants generated on a *Bak1* null background have exons 2--4 of *Bax* deleted following Cre-mediated recombination. The conditional deletion of *Bax* combined with the *Bak1* null allele greatly reduces apoptotic cell death and thus makes these mice useful in studies of apoptosis regulation ([@bib48]).

Reagents {#s4-2}
--------

Hypoxic zones in the adult hippocampus were detected using pimonidazole hydrochloride kit (Hypoxyprobe) according to manufacturer's protocol. Pimonidazole hydrichloride in water was injected intraperitoneally at a dosage of 60 mg/kg. Animals were sacrificed at 1 hr and the brain removed following cardiac perfusion. Given that the half-life of pimonidazole is 22 min in mice, \>99% of free drug had been cleared by the time of sacrifice, thus the pimonidazole imaged in our experiments was already bound at time of perfusion ([@bib57]; [@bib58]).

To examine survival of newborn cells in the adult hippocampus, mice were injected intraperitoneally with Bromodeoxyuridine (BrdU, Sigma-Aldrich, St. Louis, MO) at 300 mg/kg twice with a 4 hr interval between doses, and sacrificed at different time points. This pulse-chase protocol was chosen to saturate mitotic cell labeling within a single cell cycle as determined previously ([@bib5]). To stabilize hypoxia-inducible factor 1-α, mice were treated with dimethyloxallyl glycine (DMOG, Cayman Chemicals, Ann Arbor, MI) at 50 mg/kg intraperitoneally daily for 3 or 7 days and animals were sacrificed at different time points. The comparison group received vehicle (30% DMSO). The primary antibodies used were: anti-pimonidazole hydrochrolide (1:100, Hypoxyprobe), anti-glial fibrillary acidic protein (GFAP; 1:1000, Dako, Denmark), anti-Tbr2 (Heffner lab), anti-doublecortin (DCX, 1:500, Millipore, Billerica, MA), Anti-8-Hydroxyguanosine (1:100, Calbiochem, Billerica, MA), anti-BrdU (1:500, Abcam), anti-phospho-Akt (1:100, Cell Signalling, Danvers, MA), anti-phospho-CREB (1:300, Santa Cruz), anti-c-fos (1:300, Santa Cruz, Dalla, TX), anti-NeuN (1:500, Sigma) and anti-GAD67 (1:500, Sigma).

### Immunohistochemistry and quantitation {#s4-2-1}

Mice were terminally anesthetized according to IACUC-approved protocols, transcardially perfused with saline (4 ml, \<30 sec) followed by 20ml of 4% paraformaldehyde (PFA), and brains were post-fixed overnight. Coronal sections (100μm thick) of the hippocampus were collected from each mouse and permeabilized in 0.4% Triton in PBS (PBST) for 30 min. Sections were then blocked for 30 min with 5% horse serum in PBST and incubated overnight (4°C) with primary antibody in 5% horse serum/PBST. Sections incubated with anti-BrdU were first incubated in 2N hydrochloric acid in potassium PBST for 30 min (37°C), washed twice and blocked with horse serum as described above. After extensive washing, sections were incubated with the appropriate secondary antibody conjugated with Alexa 488, 568 or 647 (Molecular Probes, Eugene, OR), for 2 hr at room temperature. They were then washed in PBST (2 × 10 min) and mounted with Dapi Fluoromount-G (SouthernBiotech, Birmingham, AL).

For quantification of immunopositive cells, six sections offering dorsal to ventral coverage of the dentate gyrus were stained from each animal. For the BrdU survival analysis, 6--12 animals were analyzed for each time point and condition, while for the rest of the immunofluorescence quantification 3--5 animals were analyzed per group. Slides were coded and imaged by an investigator blinded to experimental condition with a Zeiss LSM780 confocal microscope under a 10x 0.45NA, 20x or 40x 0.8NA lens. A 49 μm z-stack (consisting of 7 optical sections of 7μm thickness) was obtained from every slice. For evaluation of cells densities, positive cells within the dentate gyrus per z-stack were counted (Image J) and divided by the volume of the dentate gyrus. To determine the volume of the DG quantified the cross sectional area of the dentate gyrus (Image J) was multiplied by the section thickness. Cells densities from every stack were averaged per mouse and the results were pooled to generate mean values. For normalization the density of cells in individual DMOG treated animals was normalized to the mean cell density of the animals in the control group.

### Volumetric analysis of the DG {#s4-2-2}

Measurements were taken in every sixth 49 μm coronal section stained with DAPI (Sigma-Aldrich). Sections were digitized at appropriate magnification and the areas of the dentate granule cell layer (GCL) were measured using ImageJ software. Volumes (V) were calculated as V = ΣA · *i* · *d*, according to Cavalieri´s principle, with A representing the sum of areas from both hemispheres of each section, *i* the interval between the sections, and *d* the section thickness, respectively.

### Quantitative real-time PCR {#s4-2-3}

Total RNA was isolated from dentate gyri microdissected from animals treated with either vehicle or DMOG for 3 days. RNA samples were DNAse treated using the DNAfree kit (Ambion, Carlsbad, CA) followed by an additional ethanol precipitation. cDNAs were synthesized from 200 ng of RNA using random hexamer primers from the First Strand cDNA Synthesis Kit (Fermentas, Waltham, MA). The real time reaction was performed in triplicate using FastStart SYBR Green Master (Roche, Switzerland). Quantification was performed using the efficiency-corrected ΔΔCT method. The following primers were used for qRT-PCR: HIF-1α sense CCATTCCTCATCCGTCAAATA anti-sense AAGTTCTTCCGGCTCATAAC, EPO sense CAGAGACCCTTCAGCTTCATATAG, anti-sense TCTGGAGGCGACATCAATTC, VEGF sense ACACCCACCCACATACA, anti-sense TCCAGTGAAGACACCAATAAC, Lef-1 sense AGAACACCCTGATGAAGGAAAG, antisense GTACGGGTCGCTGTTCATATT, 18S sense CGCGGTTCTATTTTGTTGGT, anti-sense TCGTCTTCGAAACTCCGACT.

### Western blot analyses {#s4-2-4}

Microdissected dentate gyri from animals treated either with vehicle or DMOG for 3 days were mechanically homogenized in RIPA lysis buffer (Thermoscientific, Waltham, MA) and samples were spun for 10min at 4^o^C. The protein concentration in the supernatant was determined using the Bradford Protein Assay and supernatants were boiled at 95^o^C for 5min. Total protein samples were separated by SDS-PAGE and equal amounts of protein (30 μg) were loaded into a 10% gradient precast gel (Invitrogen). The separated proteins were transferred on a polyvinilydine difluoride membrane by electro transfer. The membrane was then incubated sequentially with the primary antibodies \[mouse monoclonal HIF1α (Abcam, UK, Ab-1, 1:1000); mouse monoclonal β-tubulin (Developmental Studies Hybridoma Bank, Iowa City, IA, E7, 1:5000). Target proteins were detected using a chemiilluminescence ECL system (Genesys Technologies, Daly City, CA) after incubation with secondady antibody with conjugated horseradish peroxidase (anti-mouse IgG, HRP linked, Cell signalling). The blots were densitometrically analysed using Image J. The optical densities were calculated by normalising the ratio of target protein to β-tubulin.

### Retrovirus production and stereotaxic injections {#s4-2-5}

Moloney Murine Leukemia Virus-based retroviral vectors require cell mitosis for transduction and were used to identify and manipulate adult-born granule cells. Retroviruses were created using a pSie-based viral backbone, and expression was driven by a ubiquitin promoter and followed by a woodchuck posttranscriptional regulatory element ([@bib49]; [@bib26]; [@bib36]).

To study cell survival, groups of WT and *Bax^fl/fl^* mice (4--7 animals per condition) were injected with a 1:1 mixture of two viruses, the nuclear cre-GFP-expressing virus and the the mCherry-expressing virus, to control for viral injection coordinates and baseline cell survival. Mice were anesthetized using an isoflurane gas system (Veterinary Anesthesia Systems Co.) and placed in a Kopf stereotaxic frame fitted with a gas nose cone. A skin incision was made and holes were drilled at x: ± 1.1 mm, y: −1.9 mm from bregma. Using a 10 µl Hamilton syringe with a 30 ga needle and the Quintessential Stereotaxic Injector (Stoelting, Kiel, WI), 2 μl mixed viral stock (1 μl of each virus) was delivered at 0.25 µl/min at z-depths of 2.5 and 2.3 mm. The syringe was left in place for 1 min after each injection before being slowly withdrawn. The skin above the injection site was closed using veterinary glue. Animals received post-operative lidocaine and drinking water containing children\'s Tylenol. The number of GFP-expressing cells was divided by number of mCherry expressing cells for each animal.

### Electrophysiology {#s4-2-6}

Live hippocampal slices were prepared from virus-injected animals and whole cell voltage-clamp recordings to asses synaptic activity were performed from retrovirus-labeled 3 day old granule cells using a cesium gluconate-based internal. Excitatory afferents and feed-forward inhibition were stimulated with a bipolar electrode (FHC Inc., Bowdoin, ME) placed into the middle molecular layer (MML) approximately 150 um from the cells of interest, using a 0.1 msec 100 mA stimulating current. Stimulation efficacy was verified by recording from immediately adjacent mature cells (unlabeled) or by recording extracellular field potentials with an ACSF-filled glass pipette placed in the MML in the dendritic field adjacent to the immature neuron, while keeping the stimulation position and intensity constant. All recordings from mature cells or dendritic fields demonstrated clear responses to stimulation. Solutions and acute slice protocols are as reported previously ([@bib36]).

### Adult hippocampal neurospheres assay {#s4-2-7}

Adult hippocampal neurospheres were derived from 6--8 microdissected dentate gyri of 4--6 weeks old WT mice. To isolate neural progenitors from the adult hippocampus, 6--8 adult dentate gyri were isolated under a microscope in dissection media (NaCl (137 mM); KCl (5.3 mM); HEPES (10 mM); D-glucose (33 mM); sucrose (44 mM); NaHPO~4~·7H~2~O (0.167 mM); KH~2~PO~4~ (0.220 mM); phenol red (0.067 mM); 1% pen/strep), then digested with papain for 30 min (10 ml Dissection medium; 2 mg cysteine; 150 μl calcium solution (100 μM); 100 μl EDTA solution (50 mM); 200 units papain). The digestion was stopped by re-suspension in Neurocult medium (Stem Cell Technologies, Canada), tissue was triturated to a single cell suspension and filtered by 70 μm cell strainer. Primary cells were seeded at a density of 2 × 10^4^ viable cells/cm^2^ in Neurocult medium supplemented with 20ng/ml hrEGF (Peprotech), 10 ng/ml hrbFGF (Peprotech, Rocky Hill, NJ) and 2 μg/ml heparin (Sigma). To induce hypoxia primary cells were cultured in a temperature- and humidity-controlled hypoxic chamber set at 2.5% O~2~, 5% CO~2~, and 94% N~2~ (COY laboratory equipment, Grass Lake, MI). The apparatus contains a separate access chamber, as well as two pairs of work gloves, allowing manipulation of cultures in a continuously hypoxic environment. Alternatively, cells were treated every other day with hypoxia-mimetic agent DMOG (100 μM, Cayman Chemicals). After 7 days of culture the floating spheres were first attached to glass coverslips using Cell-Tak cell tissue adhesive (BD, Franklin Lakes, NJ) and then processed for further analysis.

Immunocytochemistry on neurospheres was carried out as previously described ([@bib55]). Primary antibodies used included anti-Nestin (1:200, Millipore), anti-DCX (1:700, Millipore), anti-activated Caspase-3 (1:200, Abcam), anti-pimonidazole hydrochloride (1:200, Hypoxyprobe). Immunopositive cells and total DAPI-stained nuclei were counted to calculate the percentage of immunopositive cells. Confocal images of 10 randomly picked neurospheres from three independent experiments were counted for each marker and experimental condition. Neurospheres' diameter was calculated using Image J software.

### Statistical analysis {#s4-2-8}

Statistical analysis was performed with Prism Software (GraphPad Software, La Jolla, CA). All data were obtained from n≥3 animals and expressed as mean ± standard deviation (SD). Experiments involving ≥ two groups were compared using unpaired two-tailed Students t-test or multiple-way analysis of variance (AVOVA) followed by post-hoc analysis with Sidak's multiple comparison test. Significance was defined as \*p \<0.05, \*\*p \<0.01, \*\*\*p \<0.001.
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\[Editors' note: this article was originally rejected after discussions between the reviewers, but the authors were invited to resubmit after an appeal against the decision.\]

Thank you for choosing to send your work entitled \"Differential oxygen tensions within the SGZ determine the early survival of newborn hippocampal granule cells\" for consideration at *eLife*. Your full submission has been evaluated by Eve Marder (Senior Editor), a Reviewing Editor and two peer reviewers, and the decision was reached after discussions between the reviewers and Reviewing Editor. Based on our discussions and the individual reviews below, we regret to inform you that in its present form your work will not be considered further for publication in *eLife*.

You will note that one of the reviewers was quite enthusiastic about the manuscript and the other was much less so. Nonetheless, both of them raised some of the same or similar technical issues. These include the potential of hypoxic conditions introduced in the histological processing, the reduction of mRNA by a drug that supposedly inhibits at the protein level, and whether the data support \"oxygen tension.\" Clearly, resolving these technical considerations is of paramount importance, and it isn\'t immediately obvious that this can be done in a very short time frame. If you believe that you can satisfactorily address these and the other issues raised in the reviews, the potential significance of the work would make us willing to consider a new submission of this work, which might be handled by the same or different reviewers.

*Reviewer \#1:*The authors aim to show that migration from a hypoxic area in the SGZ to outer layers of the GCL is accountable for the death of young hippocampal neuroblasts after cell division. Although the idea of oxygen tension gradient in neurogenesis regulation is interesting and supported by previous data, this paper is far from providing proofs for this mechanism and the quality of images is not satisfactory. Many of the conclusions are not supported by the data.

My detailed remarks are listed here:

[Figure 1](#fig1){ref-type="fig"}: a major concern is about the proper tissue handling when using Hypoxyprobe. According to the Methods, animals were transcardially perfused with saline (subsection "Immunohistochemistry and Quantitation"). For how long were they perfused? It is of extreme importance because a brain not exposed to blood oxygen and not fixed yet with PFA will suffer from experimentally-induced hypoxia. It is crucial for the authors to show a similar Hypoxyprobe labeling pattern when the brains are immediately immersed in PFA.

[Figure 1A](#fig1){ref-type="fig"}: the schematic should come at the end of the paper.

[Figure 1C](#fig1){ref-type="fig"} top right: how does this image correlate with the other images in the top row? Supposed to be an enlargement? It is not clear whether this cell is GFAP+ or not.

[Figure 1E](#fig1){ref-type="fig"}: where are the 8-oxo-DG cells in the two images on the right?

The authors claim that DCX+ cells are located in more external layers of the GCL and away from the SGZ but in the images presented it appears that they are localized to the same place as Tbr2+ cells.

Overall, It would also be interesting to show how many of the NSCs are positive for Hypoxyprobe and whether it correlates with their activation status.

[Figure 2A](#fig2){ref-type="fig"}: the regulation of prolyl hydroxylase on the levels of Hif1-α is at the protein level (by inducing its rapid degradation). Therefore what is the rationale for measuring Hif1-α mRNA levels? It should not be changed if prolyl hydroxylase is inhibited. Instead, the protein level should be measured.

[Figure 2B](#fig2){ref-type="fig"}: it is not clear from the image which cells are pAKT+VE.

The legends repeat the conclusion of more pAKT cells twice.

[Figure 3](#fig3){ref-type="fig"}: the staining presented is not satisfactory. DCX is way too much overexposed and nestin staining probably represents non-specific blood vessel staining. It is not clear which cells are proliferating and no conclusion can be drawn.

[Figure 3E](#fig3){ref-type="fig"}: are you sure these cells were labeled with BrdU (as indicated in y-axis)? If indeed please relate to the labeling protocol.

[Figure 4](#fig4){ref-type="fig"}: how were cell numbers normalized? Why not presenting cell numbers as \# of positive cells per area or volume unit?

It is not clear to me why the numbers of Ki67 cells were not changed but the numbers of Tbr2 increased. These markers label the same population. Also quantification for Tbr2 should be added.

[Figure 5](#fig5){ref-type="fig"}: images in [Figure 5B](#fig5){ref-type="fig"} are not representative because there are more mCherry cells in the image but more GFP cells in the quantification. The images are not of good quality. There are many double-positive cells -- how did you count them? Why are there so many red labeled cells in the hilus and outer GCL in *Bax* mutants treated with DMOG? It is not conclusive enough that the difference between *Bax* mutants treated with vehicle and *Bax* mutants treated with DMOG is due to increase in the fraction of mCherry cells. It rather can inhibit proliferation/survival of GFP cells.

[Figure 5C](#fig5){ref-type="fig"}: why connect the groups with lines?

[Figure 6](#fig6){ref-type="fig"}: I do not understand why these experiments were conducted. It was shown before (by Gage group and others) the exact timing of synapse formation. The authors did not conduct the same electrophysiology experiments on DMOG-treated animals.

[Figure 7](#fig7){ref-type="fig"}: I also do not understand why the number of neurosphere is an indication for cell survival. Does DMOG or hypoxia increase the survival of the cells in the dish that initiate the sphere? Perhaps a better experiment would be to use a DMOG-treated animal for sphere production rather than to apply it to the dish.

*Reviewer \#2:*This is a great study by Drs. Chatzi et al. The paper will have an important impact in the field of adult neurogenesis. The study is also highly significant for the field of hypoxia in general, including e.g. tumor biology. The study is particularly relevant for understanding the cognitive consequences of obstructive sleep apnea. The specificity with which the different stages of neurogenesis are affected by HIF/hypoxia is impressive.

My great enthusiasm for this paper is somewhat dampened by several aspects that need to be addressed before considering this paper for publication in *eLife*. Most of these comments relate to the hypoxic condition, which was primarily deduced from the use of molecular markers. One example is the title, which states \"oxygen tensions within the SGZ\[...\]\" yet, oxygen tensions were not really measured, but are suggested by the use of a molecular marker. I don\'t doubt the study, but the statement \"Oxygen tensions\" somehow implies that those oxygen tensions were measured. It is for example conceivable that these cells are just functioning anaerobically, i.e. they are metabolically hypoxic, but the tension may be normal? Changing the title would solve this issue. But, it is a recurrent issue, and the authors have to double check their statements: In the second section of Results, the authors state e.g. \"Mimicking hypoxia\". But, really what they (DMOG) do is stabilize Hif1-α. This, however, is only one aspect of hypoxia -- hypoxia will also affect other regulators such as HIF2. Indeed, the balance between the regulation of oxidants and anti-oxidants is one of the aspects that would differentiate chronic versus intermittent hypoxia. Stabilizing HIF1a is not addressing this important aspect of hypoxia or the regulation of the Redox state, just to name one example. In short hypoxia will cause many additional biochemical changes throughout the cellular and local niche environments, which are not accounted for by Hif1-α stabilization. Again, this is easily fixed by changing the heading, and other statements that imply that the authors \"mimicked hypoxia\" -- e.g. at the end of subsection "DMOG increases survival, but not proliferation or differentiation".

In addition to this general comment, I have also a few specific comments.

1\) Previous studies (e.g.,Hodge et al., 2008; Roybon et al., 2009) suggest that type 3 neurons can potentially be Tbr2+/DCX+. Therefore, it is recommended that the analysis be revised to pool type 2b with type 3 cells OR use Sox 11+/Prox1+ staining should the authors wish to resolve type 3 versus type 2.

2\) [Figure 3](#fig3){ref-type="fig"}: it is unclear as to how the KI67+ cell counts were normalized. The text describes KI67+ cells/field. This should be clarified since the area of SGZ will vary between sections.

3\) Given the ubiquity of HIF and the systemic application of DMOG, it would be useful for the reader to know whether stabilizing Hif1-α had any effects on macroscopic structures/volumes of the DG.

4\) The statement \"Double inmmunohistochemistry with an antibody that specifically recognizes phosphorylated Akt together with anti-DCX\" is unclear.

5\) Was the electrophysiology conducted in untreated animals? Please clarify. I also suggest that [Figure 6C,D](#fig6){ref-type="fig"} be placed in separate figures.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for resubmitting your work entitled \"Localized hypoxia within the SGZ determines the early survival of newborn hippocampal granule cells\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Eve Marder (Senior Editor), a Reviewing Editor, and three reviewers.

All reviewers are generally supportive of the potential value of your work and its suitability for publication in *eLife*. However, the consensus opinion of the reviewers is an additional set of control experiments is required before your paper can be published. These studies are meant to: (a) provide additional clarifying data on the exact cell types affected in the transition from more hypoxic to less hypoxic regions of the hippocampus; (b) improve confidence in the specificity of effects of systemically administered DMOG; (c) provide additional data supporting your conclusions about the lack of influence of synaptic activity on progenitors.

Specifically, here are the experiments suggested by the reviewers:

*Reviewer 2:* 1) For [Figure 4](#fig4){ref-type="fig"}, immunohistochemical analysis should be provided for Nestin/BrdU and Tbr2/Dcx at all time-points in which BrdU was measured. This is in line with analysis shown in [Figure 3](#fig3){ref-type="fig"} and should be feasible for the authors.

2\) For [Figure 4](#fig4){ref-type="fig"}, analysis done at 28 d.p.i specifically should include a BrdU/NeuN analysis since the major conclusion addresses survival.

*Reviewer 3:*

1\) The authors' evidence against neural progenitors receiving any synaptic inputs is weak compared to the evidence published arguing for a role of synaptic activity in modulating survival of NPCs (see Song et al., Nature Neuroscience, 2013). For instance, the authors can record from 3 day old NPCs while stimulating hilar INs or mossy cells.

2\) Retroviral expression of Hif1-α in NPCs to address non-specific effects of DMOG.

3\) Examining c-Fos in mossy cells, hilar INs at different time points during and immediately post DMOG treatment.

4\) Western blots for Hif1-α in DG of DMOG treated brains.

We hope that you agree that this limited set of experiments are reasonable and will add to the quality of your paper.

10.7554/eLife.08722.013

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

We were gratified that reviewer 2 called the paper "great", but concerned by the views of reviewer 1. The rejection was based on "technical issues" that you mentioned in your letter. Specifically, the editors' letter mentioned 3 technical issues:

1\. "...The potential of hypoxic conditions introduced in the histological processing". This is not a relevant concern based on the chemistry of the probe as we elaborate below. The methods of tissue fixation were entirely standard and in fact we had also done the less-ideal method proposed by the reviewer (immersion fixation of the entire brain) and the results were the same. We explain this further in the proposed point-by-point response to the reviewer as below.

2\. "...The reduction of mRNA by a drug that supposedly inhibits at the protein level...". The reviewer was not aware the Hif1a transcription can be autoregulated because of the presence of hypoxic response elements (HREs) in its promoter. Thus our analysis and interpretation are correct. In any case, this was a minor issue that is not critical to the overall thrust of the paper.

3\. "...Whether the data support 'oxygen tension'..." as what we measured. This point was raised by reviewer 2, and we agree that we have adjust the wording in the title, headers and text. However we used a hypoxic biosensor that we calibrated in vitro thus we think we are able to assess that regions of the subgranular zone have an oxygen tension less than 1.5%. It is true we did not use an oxygen electrode, but rather a readout of a chemical reaction.

Reviewer \#1:

The authors aim to show that migration from a hypoxic area in the SGZ to outer layers of the GCL is accountable for the death of young hippocampal neuroblasts after cell division. Although the idea of oxygen tension gradient in neurogenesis regulation is interesting and supported by previous data \[\...\].

This comment makes it sound like our paper investigated a well-understood mechanism. We disagree. Mazudmar et al. (2010) showed that oxygen regulates neural stem cells through Wnt-β catenin signaling in vitroand that deletion of hypoxia-inducible factor-1 α subunit (HIF-1α) in vivodecreased adult hippocampal neurogenesis. However the mechanisms and the developmental stages at which oxygen gradients affect adult neurogenesis remain unknown. The point of our paper was to show in vivothat heterogeneous oxygen gradients influence the survival of an early stage of neurogenesis, well before the better-studied activity-dependent survival that occurs later. These papers were cited and the topic discussed in the Introduction of the manuscript.

*\[...\] this paper is far from providing proofs for this mechanism and the quality of images is not satisfactory. Many of the conclusions are not supported by the data.*

We are able to easily address all specific comments as below.

*My detailed remarks are listed here: [Figure 1](#fig1){ref-type="fig"}: a major concern is about the proper tissue handling when using Hypoxyprobe. According to the Methods, animals were transcardially perfused with saline (subsection "Immunohistochemistry and Quantitation"). For how long were they perfused? It is of extreme importance because a brain not exposed to blood oxygen and not fixed yet with PFA will suffer from experimentally-induced hypoxia. It is crucial for the authors to show a similar Hypoxyprobe labeling pattern when the brains are immediately immersed in PFA.*

In brief, this is not a significant concern. Hydroxyprobe (pimonidazole) was delivered as a single injection and the animal was sacrificed at 60 minutes. Given that the half-life of Hydroxyprobe is 22 minutes in mice, \>99% of free drug has been cleared by the time of sacrifice. Furthermore, pimonidazole becomes reductively activated and its active intermediate binds to thiol groups in nucleic acids and proteins in hypoxic cells. Thus bound drug is not in rapid equilibrium with free drug, i.e. the pimonidazole imaged in our experiments was already bound at time of perfusion.

In terms of perfusion, a saline rinse (4 ml, \<30 sec) is standard protocol to remove blood and thus increase access of PFA to the brain, and transcardial perfusion is regarded as the most effective way to achieve rapid and complete fixation within 1 minute. Thus the saline rinse should reduce the chance of generalized hypoxia. Finally, if there was any free pimonidazole and if there was generalized hypoxia, we should have seen generalized staining as well as signs of generalized hypoxia -- we did not. In addition, rapid immersion of the brain in PFA produced similar results (data not shown). Details of the kinetics of Hydroxyprobe have been added to Methods and references added.

*[Figure 1A](#fig1){ref-type="fig"}: the schematic should come at the end of the paper.*

The schematic was introduced as the framework for the experiments, not a cartoon of the conclusions. We think this was clear, however we have modified the figure legend and text to make this explicit.

*[Figure 1C](#fig1){ref-type="fig"} top right: how does this image correlate with the other images in the top row? Supposed to be an enlargement? It is not clear whether this cell is GFAP+ or not.*

Yes, the rightmost panels were enlargements. For example, in the top row the rightmost panel shows a hypoxic cell labeled with pimonidazole (green) colocalized with the stem cell marker GFAP (yellow). The figure has been modified for clarity as has the figure legend. The point of this figure was clearly quantified in [Figure 1D](#fig1){ref-type="fig"}.

*[Figure 1E](#fig1){ref-type="fig"}: where are the 8-oxo-DG cells in the two images on the right? The authors claim that DCX+ cells are located in more external layers of the GCL and away from the SGZ but in the images presented it appears that they are localized to the same place as Tbr2+ cells.*

We did not claim that DCX+ cells are located in "more external layers of the GCL," as that is not how this tissue is organized. DCX expressing immature newborns neurons in theDG are localized in the SGZ zone and inner GCL layer as clearly depicted in our images. Newborns cells migrate in the more external layer of the GCL much later during their development ( \>2 weeks post-mitotic). We included the schematic in [Figure 1A](#fig1){ref-type="fig"} specifically to avoid such misunderstandings. Thus, as stated in the original text and obvious from the image, the 8-oxo-DG cells are located within the SGZ in the same layer with Tb2+and Tbr2+/DCX+ cells.

*Overall, It would also be interesting to show how many of the NSCs are positive for Hypoxyprobe and whether it correlates with their activation status.*

In our experiments, the vast majority of pimonidazole+ cells were neural stem cells (GFAP+), a cell type that can exist for long periods. Thus our labeling provides a single snapshot with a window of \<60 minutes (the duration of free pimonidazole in the tissue). It is not practical to count GFAP+ cells because the labeling even in confocal sections is dense, but as clearly shown in the images only a small fraction of GFAP+ cells were pimonidazole-positive. For the more short-lived intermediate progenitors (Tbr2+), 14.6 ± 1.1% of Tbr2+ cells (Type 2a cells, 100 Tbr2+ cells from 3 animals) were double labeled with pimonidazole. We did not see colabeling of pimonidzole with Ki67 (as was mentioned in the Discussion). We have further elaborated on this point in the Discussion.

*[Figure 2A](#fig2){ref-type="fig"}: the regulation of prolyl hydroxylase on the levels of Hif1-α is at the protein level (by inducing its rapid degradation). Therefore what is the rationale for measuring Hif1-α mRNA levels? It should not be changed if prolyl hydroxylase is inhibited. Instead, the protein level should be measured.*

This is not correct. Several hypoxia response elements (HREs) have been identified in the *HIF1A* promoter and implicated in an autoregulatory loop whereby HIF itself upregulates HIF-1α transcription. Thus stabilization of Hif1-α by DMOG can in turn induce an increase in Hif1-α mRNA levels. A specific anti-Hif1-α antibody is also not commercially available. This point has been added to the Results and references added.

*[Figure 2B](#fig2){ref-type="fig"}: it is not clear from the image which cells are pAKT+VE. The legends repeat the conclusion of more pAKT cells twice.*

Arrows in the original figure clearly identified the pAKT cells, but the figure has now been enlarged to make this point even clearer. The figure legend was not repetitive, it merely identified the raw data panel and the quantification in the histogram. However, we have now consolidated this wording.

*[Figure 3](#fig3){ref-type="fig"}: the staining presented is not satisfactory. DCX is way too much overexposed and nestin staining probably represents non-specific blood vessel staining. It is not clear which cells are proliferating and no conclusion can be drawn.*

We completely disagree. Nestin clearly labeled the linear radial glia fibers as expected, and thus is definitely not non-specific. It is true that Nestin labeled blood vessels in the hilus, but their distinctive morphology (horizontal vs vertical in this image) made them clearly separable. Because we used a mouse antibody, we expect blood vessel staining but this has no impact on the quantification. To avoid confusion, [Figure 3](#fig3){ref-type="fig"} has been modified to show only Ki67 immunolabeling at low power (panels A, B), and triple staining with Ki67/Nestin/DCX at higher magnification (panels C, D).

*[Figure 3E](#fig3){ref-type="fig"}: are you sure these cells were labeled with BrdU (as indicated in y-axis)? If indeed please relate to the labeling protocol.*

Yes. BrdU methodology was in the original Methods section. BrdU methods have been added to the figure legend and we have clarified the text in the subsection "DMOG increases survival, but not proliferation or differentiation".

*[Figure 4](#fig4){ref-type="fig"}: how were cell numbers normalized? Why not presenting cell numbers as \# of positive cells per area or volume unit?*

Cell counts were normalized to the vehicle-treated controls. We have now converted these numbers and plotted the figure as positive cells per tissue volume (cells/mm^3^), which has no effect on the conclusions.

*It is not clear to me why the numbers of Ki67 cells were not changed but the numbers of Tbr2 increased. These markers label the same population. Also quantification for Tbr2 should be added.*

We did not detect (or claim) a significant effect on the total density of the Tbr2+ cells; thus there is no discrepancy. We have added the data on Tbr2 (Vehicle: 5776 ± 681 cells/mm^3^, DMOG: 7331 ± 1381 cells/mm^3^, p=0.07, n= 5 animals) in the subsection "DMOG increases survival, but not proliferation or differentiation".

*[Figure 5](#fig5){ref-type="fig"}: images in [Figure 5B](#fig5){ref-type="fig"} are not representative because there are more mCherry cells in the image but more GFP cells in the quantification. The images are not of good quality. There are many double-positive cells -- how did you count them? Why are there so many red labeled cells in the hilus and outer GCL in* Bax *mutants treated with DMOG?*

The images were representative, but the reviewer has interpreted the relatively high background of the red channel in low magnifications as mCherry+ cells. There are no mCherry+ cells in the hilus and outer GCL. This is not a question of the quality of the image but due to the fact that the animals were analyzed one week post stereotaxic injections as necessary for the experiment, and mCherry in vivomatures much slower than GFP. Thus the signal/noise ratio is not as good in the red channel than in the green channel at low mag. We used high magnification images for quantification where mCherry+ cells are easily resolved as was apparent in the high mag images in the original figure. All cells including double labeled cells were counted. We have worked to improve the image quality at low magnification given the technical constraints as discussed here.

*It is not conclusive enough that the difference between* Bax *mutants treated with vehicle and* Bax *mutants treated with DMOG is due to increase in the fraction of mCherry cells. It rather can inhibit proliferation/survival of GFP cells.*

The two retrovirus strategy was used simply to allow quantification and thus these are the same population of newborn neurons. If, as the reviewer implies, DMOG inhibited proliferation or survival, GFP+ and mCherry+ cells would be equally affected and the ratio of GFP/mCherry cells unchanged. Thus we do not see this as a logical explanation of the data. We have amplified this point in the subsection "DMOG increases survival, but not proliferation or differentiation".

*[Figure 5C](#fig5){ref-type="fig"}: why connect the groups with lines?*

The panel has been replotted as a histogram.

*[Figure 6: I](#fig6){ref-type="fig"} do not understand why these experiments were conducted. It was shown before (by Gage group and others) the exact timing of synapse formation. The authors did not conduct the same electrophysiology experiments on DMOG-treated animals.*

There is conflicting evidence in the literature concerning the timing of first synaptic activity and its influence on cell survival. Given that even small amounts of neural activity can have an impact, we think high quality data in this regard is critical and it is key to our conclusion that this early period of cell survival is independent of neural activity. It could be a supplemental figure, but given *eLife's* format we think it is better included as a regular figure. We see no rationale for repeating the electrophysiology in DMOG-treated animals, given that DMOG did not affect the surrogate activity markers pCREB or c-Fos.

*[Figure 7: I](#fig7){ref-type="fig"} also do not understand why the number of neurosphere is an indication for cell survival. Does DMOG or hypoxia increase the survival of the cells in the dish that initiate the sphere?*

The number of neurospheres is a standard measure in the stem cell field to assess survival. Because the seeding density of dissociated cells for neurosphere formation was the same for all conditions, the total number of neurospheres reflects the survival of the progenitors.

*Perhaps a better experiment would be to use a DMOG-treated animal for sphere production rather than to apply it to the dish.*

We don't see this as an interpretable experiment. The reason for using neurospheres is that we can control the oxygen levels and the concentration of DMOG. The in vivotissue oxygen concentration is much lower than the oxygen concentration used for routine cell cultures (room air, 21%). The ability to compare the effects of real hypoxic conditions with DMOG treatment on progenitors in vitroprovides a valuable calibration tool with clean readouts.

Reviewer \#2:

*My great enthusiasm for this paper is somewhat dampened by several aspects that need to be addressed before considering this paper for publication in* eLife*. Most of these comments relate to the hypoxic condition, which was primarily deduced from the use of molecular markers. One example is the title, which states \"oxygen tensions within the SGZ\[...\]\" yet, oxygen tensions were not really measured, but are suggested by the use of a molecular marker. I don\'t doubt the study, but the statement \"Oxygen tensions\" somehow implies that those oxygen tensions were measured. It is for example conceivable that these cells are just functioning anaerobically, i.e. they are metabolically hypoxic, but the tension may be normal? Changing the title would solve this issue. But, it is a recurrent issue, and the authors have to double check their statements: In the second section of Results, the authors state e.g. \"Mimicking hypoxia\". But, really what they (DMOG) do is stabilize Hif1-α. This, however, is only one aspect of hypoxia -- hypoxia will also affect other regulators such as HIF2. Indeed, the balance between the regulation of oxidants and anti-oxidants is one of the aspects that would differentiate chronic versus intermittent hypoxia. Stabilizing HIF1a is not addressing this important aspect of hypoxia or the regulation of the Redox state, just to name one example. In short hypoxia will cause many additional biochemical changes throughout the cellular and local niche environments, which are not accounted for by Hif1-α stabilization. Again, this is easily fixed by changing the heading, and other statements that imply that the authors \"mimicked hypoxia\" -- e.g. at the end of subsection "DMOG increases survival, but not proliferation or differentiation"*.

We have changed the title, wordings and section headers to address this issue. We agree with the reviewer that this does not change the conclusions of the manuscript.

*In addition to this general comment, I have also a few specific comments. 1) Previous studies (e.g., Hodge et al., 2008; Roybon et al., 2009) suggest that type 3 neurons can potentially be Tbr2+/DCX+. Therefore, it is recommended that the analysis be revised to pool type 2b with type 3 cells OR use Sox 11+/Prox1+ staining should the authors wish to resolve type 3 versus type 2.*

We agree that our staining paradigm cannot differentiate between Type 2b and Type 3 cells. We have revised the analysis and data have been plotted as percentages of Tbr2+/DCX-, Tbr2+/DCX+ and Tbr2-/DCX+ cells and the text reworded in the subsection "DMOG increases survival, but not proliferation or differentiation".

*2) [Figure 3](#fig3){ref-type="fig"}: it is unclear as to how the KI67+ cell counts were normalized. The text describes KI67+ cells/field. This should be clarified since the area of SGZ will vary between sections.*

Ki67 cells counts are now expressed as fold increases of Ki67cells/mm^3^ in DMOG vs. vehicle-treated animals. For normalization the density of Ki67+ cells in individual DMOG treated animals was normalized to the mean cell density of the animals in the control group (see Methods).

*3) Given the ubiquity of HIF and the systemic application of DMOG, it would be useful for the reader to know whether stabilizing Hif1-α had any effects on macroscopic structures/volumes of the DG.*

Administration of DMOG had no effect on the DG volume (Control: 0.61mm^3^ ± 0.02, n=3 animals, DMOG: 0.59 ± 0.04, n=animals, p=0.89). This point has been added to the text in the subsection "DMOG increases survival, but not proliferation or differentiation".

*4) The statement \"Double inmmunohistochemistry with an antibody that specifically recognizes phosphorylated Akt together with anti-DCX\" is unclear.*

The statement has now been better explained in the subsection "Stabilizing Hypoxia Inducible Factor-1α" as follows: "Double immunohistochemistry with an antibody that specifically recognizes phosphorylated Akt together with an antibody against the neuroblast/immature neuron marker doublecortin (DCX)\[...\]"

*5) Was the electrophysiology conducted in untreated animals? Please clarify. I also suggest that [Figure 6C and D](#fig6){ref-type="fig"} be placed in separate figures.*

Yes, the electrophysiology was done in control animals as the question was whether there is any synaptic activity at this stage. We prefer to keep the activity-related panels together in one figure, but we have clarified that [Figure 6A](#fig6){ref-type="fig"} refers to the lack of electrical activity in 3-day-old cells in control animals and [Figure 6B and C](#fig6){ref-type="fig"} address the effect of DMOG on overall activity, which addresses whether non-cell autonomous neural activity could explain the effect of DMOG. This point has been further clarified in the subsection "Role of neuronal activity".

\[Editors' note: the author responses to the re-review follow.\]

Reviewer 2:

*1) For [Figure 4](#fig4){ref-type="fig"}, immunohistochemical analysis should be provided for Nestin/BrdU and Tbr2/Dcx at all time-points in which BrdU was measured. This is in line with analysis shown in [Figure 3](#fig3){ref-type="fig"} and should be feasible for the authors.*

The reviewer wanted us to document the phenotype of BrdU+ cells at each of the time points used in the survival experiments. This is now included in [Figure 3G](#fig3){ref-type="fig"}. We used triple immunolabeling for Tbr2/DCX/BrdU. The data has been plotted as percentages of Tbr2+/DCX-, Tbr2+/DCX+, Tbr2-/DCX+ and unlabeled cells (i.e. mature cells at 21 and 28 dpi that no longer label with DCX or Tbr2, and rare stem cells at dpi 3). Nestin and Tbr2 antibodies were raised in the same animal and thus could not be used together, but Tbr2/DCX/BrdU address the same issue. These additional experiments do not alter any of the conclusions. ([Figure 3](#fig3){ref-type="fig"}, [Figure 3](#fig3){ref-type="fig"} legend and the text in the subsection "DMOG increases survival, but not proliferation or differentiation" have been revised.)

*2) For [Figure 4](#fig4){ref-type="fig"}, analysis done at 28 d.p.i specifically should include a BrdU/NeuN analysis since the major conclusion addresses survival.*

We have now included BrdU/NeuN analysis at 28 d.p.i. for animals exposed to vehicle or DMOG for the first 3 and 7 days post-mitosis -- the two time-windows during which DMOG promoted survival of newborn cells. At 28 d.p.i. \>95% of BrdU+ cells were also NeuN+ follow 3 or 7 day treatment with vehicle or DMOG. These experiments provide further support that surviving cells fully differentiate into mature neurons by 28 days post mitosis. For the convenience of the reviewer, we have included [Author response image 1](#fig8){ref-type="fig"} with this same data, which is now included in the text in the subsection "DMOG increases survival, but not proliferation or differentiation".10.7554/eLife.08722.010Author response image 1.The percentage of BrdU+ cells in the GCL that was positive for the mature neuronal marker NeuN at 28 d.p.i. was similar between vehicle or DMOG treated animals during the two time-windows (0-3 and 0-7 days) of treatment that promoted survival of newborn neurons.(0-3 days, Vehicle: 96 ± 4, DMOG: 95 ± 2 n=3; 0-7 days, Vehicle: 98 ± 3, DMOG: 96 ± 2, n=3).**DOI:** [http://dx.doi.org/10.7554/eLife.08722.010](10.7554/eLife.08722.010)

Reviewer 3:

*1) The authors' evidence against neural progenitors receiving any synaptic inputs is weak compared to the evidence published arguing for a role of synaptic activity in modulating survival of NPCs (see Song et al., Nature Neuroscience, 2013). For instance, the authors can record from 3 day old NPCs while stimulating hilar INs or mossy cells.*

We strongly disagree that our evidence was "weak". We also think the reviewer overstates the prior evidence, which was at 4 days post-mitosis in which they state that "14%" of their cells had some activity at high stimulation intensity, but the example shown in that paper does not fit with the expected kinetics of a GABAergic response. Thus we don\'t know how to interpret that data.

In any case, we did not find any evidence for synaptic innervation of immature adult-born granule cells at 3 days post-mitosis, based on assays of spontaneous events and the lack of response to high intensity 8 Hz stimulation synaptic responses. Reviewer 3 suggests that stimulation within the middle molecular layer (MML) could have missed possible synaptic connections arising from hilar cells (interneurons or mossy cells). However, hilar basket cells and hilar mossy cells are driven by excitatory feed-forward inputs from the perforant path (which we stimulated directly) as well as inputs from dentate granule cell mossy fiber axons (see Ribak, CE and Shapiro, LA (2007) Ultrastucture and connectivity of cell types in the adult dentate gyrus. in Scharfman, H.E (ed) The Dentate Gyrus, 157-160). To prove explicitly that our stimulation activates hilar cells, we stimulated the MML using the same stimulating electrode position, intensity, and train duration/frequency as shown in the manuscript and assayed hilar neurons with cell-attached and current-clamp recordings (n=4 cells). In every cell, we elicited depolarization, and in 3 of 4 cells, the cells showed repetitive spiking ([Author response image 2](#fig9){ref-type="fig"}). Thus hilar cells were activated in the protocol shown in the manuscript, yet no neural activity in the 3 day-old cells was observed. We think this evidence is unequivocal that the cells at 3 d.p.i show no neural activity, thus justifying the conclusions in our manuscript. This point is now included in the subsection "Role of neuronal activity".10.7554/eLife.08722.011Author response image 2.Hilar neuron activation by MML 8 Hz stimulation.A bipolar stimulating electrode was placed in the middle molecular layer of the dentate gyrus of a mouse hippocampal slice, and a whole-cell current clamp recording was made from a hilar neuron. In this example, the hilar neuron spiked reliably in response to each stimulation episode (dot above trace). Scale bars, 20mV, 0.5 sec.**DOI:** [http://dx.doi.org/10.7554/eLife.08722.011](10.7554/eLife.08722.011)

2\) Retroviral expression of Hif1-α in NPCs to address non-specific effects of DMOG.

This is not a practical experiment, as expression of a construct requires several days post-retroviral injection, thus assay at 3 days would not be interpretable. Even if one was able to overexpress Hif1-α, it is rapidly degraded in normoxia, which is exactly the reason that DMOG (which inhibits the hydrolase that degrades Hif1-α) is useful. With regard to "non-specific" effects of DMOG, this reagent has been well studied in other systems and has proven to be highly specific.

*3) Examining c-Fos in mossy cells, hilar INs at different time points during and immediately post DMOG treatment.*

The manuscript showed that DMOG did not affect neuronal activity in the dentate as measured by c-Fos immunohistochemistry at 3 d.p.i. The reviewer wanted us to also show similar data for hilar neurons. Thus we performed double immunohistochemistry with c-Fosand the GABAergic marker glutamic acid decarboxylase-67 (Gad-67). This paradigm allowed us to differentiate between activated hilar mossy cells (Fos+ only) and active hilar interneurons (Fos+/GAD67+). In general were very few activated (Fos+) hilar mossy cells or interneurons in the vehicle-treated animals (Vehicle: Fos only+: 144 ± 55 cells/mm^3^, n=4, Fos+/GAD67+: 14 ± 16 cells/mm^3^, n=4). DMOG treatment did not affect the density of Fos+ cells in the hilus (DMOG,Fos only+: 116 ± 14 cells/mm^3^, n=4, Fos+/GAD67+ve: 13 ± 14 cells/mm^3^, n=4, p=0.4). These data further support our findings that DMOG's effect on survival is activity-independent. These data are now included in the subsection "Role of neuronal activity".

*4) Western blots for Hif1-α in DG of DMOG treated brains.* We have added Western blots of Hif1-α in whole dentate gyrus to [Figure 2](#fig2){ref-type="fig"} (new panel B). The data are consistent with the gene expression level in the original manuscript and show that Hif1-α protein is higher in DMOG treated animals. This was also predicted from the data in the original manuscript showing changes in mRNA of downstream targets of HIF1a, an effect that requires changes in Hif1-α protein. Text describing these data has been added to the subsection "Stabilizing Hypoxia Inducible Factor-1α".
